Last reviewed · How we verify

Prostaglandin E2 — Competitive Intelligence Brief

Prostaglandin E2 (Prostaglandin E2) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Prostaglandin analog. Area: Multiple (Obstetrics, Gastroenterology, Rheumatology).

marketed Prostaglandin analog Prostaglandin E receptors (EP1, EP2, EP3, EP4) Multiple (Obstetrics, Gastroenterology, Rheumatology) Small molecule Live · refreshed every 30 min

Target snapshot

Prostaglandin E2 (Prostaglandin E2) — Shaare Zedek Medical Center. Prostaglandin E2 (PGE2) binds to prostaglandin E receptors (EP1-EP4) on cell surfaces to modulate inflammation, smooth muscle contraction, and various physiological processes.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Prostaglandin E2 TARGET Prostaglandin E2 Shaare Zedek Medical Center marketed Prostaglandin analog Prostaglandin E receptors (EP1, EP2, EP3, EP4)
Lumigan BIMATOPROST marketed Prostaglandin Analog [EPC] Aldo-keto reductase family 1 member C3 2001-01-01
Travatan TRAVOPROST marketed Prostaglandin Analog [EPC] Prostaglandin F2-alpha receptor 2001-01-01
Xalatan LATANOPROST Thea Pharma marketed Prostaglandin Analog [EPC] Prostaglandin F2-alpha receptor 1996-01-01
Cytotec Misoprostol Pfizer marketed NSAID combined with prostaglandin analog Cyclooxygenase (COX-1 and COX-2); Prostaglandin receptors 1988-01-01
Caverject ALPROSTADIL Pfizer marketed Prostaglandin Analog [EPC] Prostaglandin E2 receptor EP3 subtype 1981-01-01
Hemabate CARBOPROST Pfizer marketed Prostaglandin Analog Prostaglandin F2-alpha receptor 1979-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Prostaglandin analog class)

  1. Allergan · 3 drugs in this class
  2. AbbVie · 2 drugs in this class
  3. Bnai Zion Medical Center · 1 drug in this class
  4. Ibis Reproductive Health · 1 drug in this class
  5. Ocuwize LTD · 1 drug in this class
  6. Shaare Zedek Medical Center · 1 drug in this class
  7. University Medical Centre Maribor · 1 drug in this class
  8. University of North Carolina, Chapel Hill · 1 drug in this class
  9. University of Pennsylvania · 1 drug in this class
  10. Wolfson Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Prostaglandin E2 — Competitive Intelligence Brief. https://druglandscape.com/ci/prostaglandin-e2. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: